Trials / Completed
CompletedNCT00269191
A Study to Assess the Safety and Efficacy of an Investigational Drug in Patients With Osteoarthritis (0663-071)(COMPLETED)
A 12-Week, Randomized, Placebo- and Active-Comparator-Controlled, Parallel-Group, Double-Blind Study to Assess the Safety and Efficacy of Etoricoxib 30 mg Versus Ibuprofen 2400 mg in Patients With Osteoarthritis (Study 1)
- Status
- Completed
- Phase
- Phase 3
- Study type
- Interventional
- Enrollment
- 528 (actual)
- Sponsor
- Organon and Co · Industry
- Sex
- All
- Age
- 40 Years
- Healthy volunteers
- Not accepted
Summary
This study was conducted to assess the safety and tolerability of the drug and to evaluate its efficacy in the treatment of osteoarthritis of the hip or knee in men and women.
Conditions
Interventions
| Type | Name | Description |
|---|---|---|
| DRUG | MK0663, etoricoxib / Duration of Treatment 12 Weeks | |
| DRUG | Placebo or Ibuprofen / Duration of Treatment 12 Weeks |
Timeline
- Start date
- 2003-02-05
- Primary completion
- 2003-11-07
- Completion
- 2003-11-21
- First posted
- 2005-12-23
- Last updated
- 2024-08-15
Source: ClinicalTrials.gov record NCT00269191. Inclusion in this directory is not an endorsement.